Document Detail


High-dose tamoxifen in treatment of brain tumors: interaction with antiepileptic drugs.
MedLine Citation:
PMID:  7614929     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The incidence of seizures related to primary brain tumors is 20-80%. High-dose tamoxifen was recently reported as a novel treatment for patients with malignant gliomas who have failed standard therapies. Tamoxifen inhibits protein kinase C (PKC) in vitro and thus may regulate glioma cell growth by modulating intracellular signal transduction. We report a patient with a recurrent supratentorial pilocytic astrocytoma who had an untoward interaction between high-dose tamoxifen therapy and phenytoin (PHT), drugs that share a common enzyme for metabolism, therefore emphasizing the need to monitor concomitant antiepileptic drug (AED) levels when high-dose tamoxifen therapy is instituted.
Authors:
A L Rabinowicz; D R Hinton; P Dyck; W T Couldwell
Related Documents :
23541929 - Impact of flow pulsatility on arterial drug distribution in stent-based therapy.
24347979 - Anti-vascular endothelial growth factor drugs safety and efficacy in ophthalmic diseases.
23484869 - The quest for developing new treatments from imaging techniques: promises, problems and...
19396339 - Clinical perspectives on lacosamide.
23744599 - Recent findings on the mechanisms involved in tenofovir resistance.
22934779 - Medicinal chemistry of drugs with active metabolites (n-, o-, and s-dealkylation and so...
22823169 - Cell-based apoptosis assays in oncology drug discovery.
14632589 - Premature ejaculation associated with citalopram withdrawal.
18964799 - Photometric and amperometric flow-injection determination of triazolam and clotiazepam.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Epilepsia     Volume:  36     ISSN:  0013-9580     ISO Abbreviation:  Epilepsia     Publication Date:  1995 May 
Date Detail:
Created Date:  1995-08-22     Completed Date:  1995-08-22     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  2983306R     Medline TA:  Epilepsia     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  513-5     Citation Subset:  IM    
Affiliation:
USC Epilepsy Center, University of Southern California School of Medicine, Los Angeles, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Brain Neoplasms / drug therapy*,  enzymology
Cell Division / drug effects
Drug Interactions
Glioma / drug therapy*,  enzymology
Humans
Magnetic Resonance Imaging
Male
Phenytoin / adverse effects,  pharmacology*
Protein Kinase C / antagonists & inhibitors
Signal Transduction / drug effects
Tamoxifen / pharmacology,  therapeutic use*
Chemical
Reg. No./Substance:
10540-29-1/Tamoxifen; 57-41-0/Phenytoin; EC 2.7.11.13/Protein Kinase C

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Linear intracerebral calcification after depth electrode implantation.
Next Document:  Effect of ozone on respiratory responses in subjects with asthma.